Rankings
▼
Calendar
MRVI Q4 2019 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$970M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$36M
Gross Profit
$18M
50.4% margin
Operating Income
$1M
3.6% margin
Net Income
-$5M
-15.0% margin
EPS (Diluted)
$-0.06
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$4M
Stock-Based Comp.
$516,000
Balance Sheet
Total Assets
$578M
Total Liabilities
$433M
Stockholders' Equity
$141M
Cash & Equivalents
$25M
← FY 2019
All Quarters
Q1 2020 →
